P

Inventor

VISWANATHAN KARTHIK

US51 patents
⚠️ This page may combine multiple inventors who share the name “VISWANATHAN KARTHIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VISTERRA INC

29 patents
US9212217B2Dec 15, 2015

Antibody molecules to dengue virus and uses thereof

VISTERRA INC14 citations92
US9096657B2Aug 4, 2015

HA binding agents

VISTERRA INC13 citations92
US8877200B2Nov 4, 2014

HA binding agents

VISTERRA INC17 citations92
US10800835B2Oct 13, 2020

HA binding agents

VISTERRA INC4 citations84
US9969794B2May 15, 2018

HA binding agents

VISTERRA INC7 citations84
US11136385B2Oct 5, 2021

Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule

VISTERRA INC4 citations83
US10954296B2Mar 23, 2021

Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA

VISTERRA INC4 citations83
US10385123B2Aug 20, 2019

Antibody molecules to a proliferation-inducing ligand (APRIL)

VISTERRA INC8 citations83
US10155806B2Dec 18, 2018

Antibody molecules to dengue virus and uses thereof

VISTERRA INC4 citations83
US9365639B2Jun 14, 2016

Antibody molecules to dengue virus and uses thereof

VISTERRA INC9 citations83
US11059883B2Jul 13, 2021

Antibody molecules to dengue virus and uses thereof

VISTERRA INC2 citations72
US10981982B2Apr 20, 2021

Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)

VISTERRA INC1 citations72
US10968270B2Apr 6, 2021

Antibody molecules to a proliferation-inducing ligand (APRIL)

VISTERRA INC3 citations72
US11912781B2Feb 27, 2024

Humanized complement 5A receptor 1 antibodies and methods of use thereof

VISTERRA INC1 citations71
US11168131B2Nov 9, 2021

Antibody molecule-drug conjugates and uses thereof

VISTERRA INC4 citations69
US10513553B2Dec 24, 2019

Compositions and methods for treating and preventing influenza

VISTERRA INC6 citations67
US12054539B2Aug 6, 2024

Antibody molecules to dengue virus and uses thereof

VISTERRA INC0 citations62
US12024552B2Jul 2, 2024

Ha binding agents

VISTERRA INC0 citations62
US12415865B2Sep 16, 2025

Antibody molecules to C5AR1 and uses thereof

VISTERRA INC0 citations61
US12187807B2Jan 7, 2025

Antibody molecules to C5AR1 and uses thereof

VISTERRA INC0 citations61
US12091451B2Sep 17, 2024

Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)

VISTERRA INC0 citations61
US11773179B2Oct 3, 2023

Antibody molecules to C5aR1 and uses thereof

VISTERRA INC0 citations61
US12338291B2Jun 24, 2025

Humanized antibody molecules to CD138 and uses thereof

VISTERRA INC0 citations60
US12264203B2Apr 1, 2025

Humanized complement 5a receptor 1 antibodies and methods of use thereof

VISTERRA INC0 citations60
US12227587B2Feb 18, 2025

Humanized complement 5A receptor 1 antibodies and methods of use thereof

VISTERRA INC0 citations60
US11945868B2Apr 2, 2024

Antibody molecules to CD138 and uses thereof

VISTERRA INC1 citations59
US11858980B2Jan 2, 2024

Engineered polypeptides and uses thereof

VISTERRA INC0 citations59
US11890319B2Feb 6, 2024

Antibody molecule-drug conjugates and uses thereof

VISTERRA INC0 citations49
US11969476B2Apr 30, 2024

Antibody molecule-drug conjugates and uses thereof

VISTERRA INC0 citations46

DONALDSON CO INC

6 patents

MASSACHUSETTS INST TECHNOLOGY

4 patents

SASISEKHARAN RAM

2 patents

BOSQUES CARLOS

1 patent

RAMAN RAHUL

1 patent

JAYARAMAN AKILA

1 patent

BLAISDELL JARED DEAN

1 patent

THARAKARAMAN KANNAN

1 patent

NIIT TECH LTD

1 patent

FRESHDESK INC

1 patent

CHARLES STARK DRAPER LABORATORY INC

1 patent

FORD GLOBAL TECH LLC

1 patent

Showing the top 50 of 51 patents by PatentIndex Score.